PeerLINC helps expand access to improved DR-TB treatments across Asia, new research shows

New findings presented at the 9th International Scientific Conference on Seeking Ways to Eliminate Tuberculosis in Asia highlight the experience of PeerLINC Knowledge Hub in supporting countries as they adopt and scale up shorter, more effective, and more people-friendly drug-resistant tuberculosis (DR-TB) treatments. Preliminary program data collected from participating PeerLINC alumni countries show that approximately 33,000 people had been reported as enrolled in newer treatment regimens by 2025.

Dr. Eden Mendoza-Hisey presented the abstract, “Regional learning networks to accelerate the adoption of WHO-recommended DR-TB regimens in Asia,” developed by authors from PeerLINC, TB Alliance, and the Tropical Disease Foundation.

While WHO recommends six-month all-oral BPaL/BPaLM regimens, which offer shorter, simpler, more effective treatment for DR-TB, adoption remains uneven across countries due to operational, clinical, laboratory, and training barriers. Dr. Mendoza-Hisey’s presentation focused on how a regional learning network can help countries address these barriers and shorten the gap between adopting new treatment policies and putting them into routine practice.

Peer-to-Peer Learning for Innovative Cures (PeerLINC) Knowledge Hub brings together peer exchange, technical assistance, case-based learning, and adaptable learning modules to help healthcare professionals and national TB programs overcome implementation challenges and expand access to improved treatments. The network has since engaged 48 countries in Asia alone, including the Philippines, Cambodia, Mongolia, India, China, and Bangladesh.

The abstract concluded that PeerLINC offers a scalable, country-responsive learning model that combines structured training, peer sharing, and demand-driven modules. Its strong satisfaction ratings and adaptable content suggest this approach can support the safe, practical rollout of WHO-recommended DR-TB regimens and improve timely access to better treatment.

The findings offer useful insight into how regional learning networks support countries as they work through the practical challenges of implementing newer DR-TB regimens. While treatment uptake is shaped by multiple factors, PeerLINC’s experience shows how practical training, shared expertise, and country-responsive support can contribute to the broader effort to translate treatment recommendations into routine practice.

Next
Next

PeerLINC Webinar Highlights Early Monitoring of Adverse Events in DR-TB Care